News

U.S. Recommends Pausing Use Of Johnson & Johnson Vaccine Over Blood Clot Concerns

By Scott Neuman
Published April 13, 2021 at 7:10 AM CDT
  • Twitter
  • LinkedIn
  • Email
NewshealthCOVID-19coronavirus vaccinecoronaviJohnson & Johnson
  • Twitter
  • LinkedIn
  • Email
Scott Neuman
Scott Neuman is a reporter and editor, working mainly on breaking news for NPR's digital and radio platforms.
See stories by Scott Neuman
Related Content
  1. After 12 Weeks Of Decline, Kentucky COVID-19 Cases Plateau
  2. Vaccine Refusal May Put Herd Immunity At Risk, Researchers Warn
  3. Kentucky Distillery Ultra-Cold Freezer on Loan to Regional Pharmacy for Pfizer Vaccine
  4. Kentucky Slightly Exceeding National Vaccination Rate Even As Doses Go Unused
  5. FAQ: What Is A Vaccine 'Passport,' And What Are These Credentials Used For?